A specialty pharmaceutical company focused on acquiring, licensing, and commercializing late‑stage medicines primarily in cardiovascular and central nervous system disorders. Its portfolio includes products such as Vascepa for cardiovascular risk reduction and Clozaril for treatment‑resistant schizo...
No congressional trades have been disclosed for HLS Inc (HLS) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.